Zealand Pharma A/S
ZEAL
ISIN DK0060257814 / Valor 11983050
Zealand Pharma A/S
UMushroom community rating:
About company
Zealand Pharma A/S is a biotechnology company based in Denmark, specializing in the development of peptide-based therapeutics. The company focuses on creating innovative treatments for diseases with significant unmet medical needs, particularly in areas where peptide therapies can offer substantial benefits. Zealand Pharma is actively engaged in addressing major health challenges such as obesity and its related complications, including cardiovascular and liver diseases, type 2 diabetes, and neuroinflammation. Additionally, the company is exploring the potential of peptide medicines in treating chronic inflammatory diseases, aiming to provide new solutions for conditions that can lead to severe health issues. Through its research and development efforts, Zealand Pharma seeks to deliver differentiated product candidates that can improve patient outcomes in these critical areas.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
3249 M
Market cap (USD)
330,616
Daily traded volume (Shares)
746.5 / 713
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
